TMA Stats & Data

Rationale and harm-reduction augmentations (with sources):

- Dosing range and slow onset: Erowid’s TMA-series summary lists TMA at 100–250 mg with 6–8 h duration; the come-up can exceed an hour. This supports keeping initial doses lower than historical “common” levels and avoiding early redoses. Slow onsets are a frequent cause of accidental overconsumption.

- Cardiovascular load: As an amphetamine, TMA can increase heart rate and blood pressure; combining with other stimulants substantially raises risks of hyperthermia, rhabdomyolysis, and acute cardiac/neurological events. Dose in a cool environment, avoid vigorous activity/saunas, and hydrate normally (not excessively).

- MAOI combinations: Harmala MAOIs and pharmaceutical MAOIs can markedly potentiate and prolong phenethylamine psychedelics; mescaline + harmala reports describe large intensity/duration increases. Treat TMA + MAOI as dangerous.

- Insomnia planning: Residual stimulation can persist after the psychological peak; dose early in the day and plan for sleep hygiene post-experience.

- Tolerance and spacing: Phenethylamine psychedelics such as mescaline show rapid tolerance and cross-tolerance to other classical psychedelics; spacing by at least 7–14 days reduces blunted responses and compulsive redosing.

- Identity risk and drug checking: TMA is rare and has historically been confused with other amphetamine psychedelics; verify identity with lab-based drug checking wherever available. At minimum, use multi-reagent testing with skepticism; a Reddit report documents a TMA sample verified by Saferparty, underscoring the value of lab confirmation.

- Accurate measurement: Because active doses are in the 100–250 mg range and batches vary, weigh doses with a reliable milligram scale; premeasure, avoid rushing, and consider an allergy test.

- Legal risk: In the U.S., TMA is a Schedule I substance under the CSA; legal penalties can be severe. Verify your local laws.

- Medical exclusions: Those with cardiovascular disease, uncontrolled hypertension, arrhythmias, or significant anxiety disorders should avoid TMA due to amphetamine-like physiological stress and potential for panic. Seek medical advice if unsure.